Clinical Trial 38822

share

Woodstock, GA 30189


Study Summary:

The primary objective of the study is to evaluate the efficacy of fasinumab compared to placebo, when administered for up to 24 weeks in patients with osteoarthritis (OA) of the knee or hip.

The secondary objectives of the study are: to evaluate the efficacy of fasinumab compared to non-steroidal anti-inflammatory drugs (NSAID)s, when administered for up to 24 weeks in patients with OA of the knee or hip; to assess the safety and tolerability of fasinumab compared to placebo and compared to NSAIDs, when administered for up to 24 weeks in patients with OA of the knee or hip


Qualified Participants Must:

• Be 18 years and older
• Clinical diagnosis of OA of the knee or hip
• Be willing to discontinue current pain medications
• Have a history of at least 12 weeks of inadequate pain relief


Qualified Participants May Receive:

May receive compensation for time and travel.  Any procedures required for this study will be provided.


Research Site Profile

View Clinic Profile


Study is Available At:

North Georgia Clinical Research
1192 Buckhead Crossing
Suite A
Woodstock, GA 30189
View Clinic Location

 


If you would like to get the phone number or be contacted by the clinical trial representative and live within 25 miles of this clinic, please enter your contact information, then click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.